Mullerian Inhibiting Substance
Taylor, Lesli A.
Massachusetts General Hospital, Boston, MA, United States
See 4 grants from Lesli Taylor
See 24696 grants from Massachusetts General Hospital
Recent in Grantomics:
University of Virginia
vs. funders. Who wins?
How should you pick the next fundable research topic?
Recently viewed grants:
Long noncoding RNAs in alcoholic liver disease
Signaling in the retina and retinal pigment epithelium
Recovery Roadmap: A Collaborative Multimedia Tool for Person-Centered Care Planni
NIREP: Non-rigid Image Registration Evaluation Project
Acquisition of A Modern Electron Microprobe
Recently added grants:
Quantitative Image Analysis for Assessing Response to Breast Cancer Therapy
Cytokine induced RelB/p50 complexes drive mesenchymal glioma progression
Multifunctional polymeric carriers for the intracellular delivery of protein cancer therapeutics
Shaping DNA Damage Response Networks Via Histone H2A Variants
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
National Institute of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Postdoctoral Individual National Research Service Award (F32)
Clinical Sciences Subcommittee 1 (CLN)
Massachusetts General Hospital
MacLaughlin, D T; Levin, R K; Catlin, E A et al.
Identification of mullerian inhibiting substance specific binding in human cell lines.
Horm Metab Res 24:570-5
Be the first to comment on Lesli Taylor's grant
Share this grant: